熱門資訊> 正文
Waldencast将从纳斯达克退市，计划在“MLKA”下进行场外交易
2026-09-14 19:42
- Waldencast (WALD) said it plans to voluntarily delist its Class A shares and warrants from Nasdaq following the divestiture of Obagi Medical.
- The company expects October 2 to be the last Nasdaq trading day and plans to suspend its SEC reporting obligations following the delisting.
- Waldencast said the move will lower public-company costs and allow it to focus on its sole remaining brand, Milk Makeup. It expects to seek OTC trading under the ticker “MLKM,” although there is no guarantee trading will begin.
- The board will also recommend renaming the company Milk Makeup plc, subject to shareholder approval.
- Waldencast incurred $18.5M in central headquarters costs in 2025 and expects to eliminate a substantial portion of those costs.
- The stock price slumped about 15% on Monday pre-market hours of trading.
More on Waldencast
- Seeking Alpha’s Quant Rating on Waldencast
- Historical earnings data for Waldencast
- Financial information for Waldencast
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
